Oncology

Latest News

COA logo | Image Credit: © Amy Kinnamon
Community Oncology Reacts to Trump's Drug Pricing Executive Order

May 2nd 2025

An executive order signed on Tuesday, May 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.

Melanoma & Skin Cancer Awareness Month | Image credit: Waseem Ali Khan - stock.adobe.com
5 Things You Should Know About Skin Cancer

May 2nd 2025

stethoscopewithcompass | Image Credit: © Talaj-stock.adobe.com
Patient Navigation Is Nonnegotiable in Cancer Care

May 1st 2025

Liver cancer - Sebastian Kaulitzki - stock.adobe.com.jpg
Elevated HLA-G Seen in HCC Driven by Viral Infections, Fatty Liver

May 1st 2025

Doctor carrying documentation for patient care | image credit: Kanisorn - stock.adobe.com.jpeg
NCODA Outlines New Patient-Centered Oncology Distribution Models

May 1st 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

PD-1 and Other Systemic Treatment Options for CSCC
December 19th 2019

PD-1 and Other Systemic Treatment Options for CSCC

Using Immunotherapy in CSCC
December 19th 2019

Using Immunotherapy in CSCC

Systemic Treatment of CSCC
December 19th 2019

Systemic Treatment of CSCC

Standard of Care for CSCC
December 19th 2019

Standard of Care for CSCC

Overview of Cutaneous Squamous Cell Carcinoma
December 19th 2019

Overview of Cutaneous Squamous Cell Carcinoma

Site Logo
December 18th 2019

Radiation Oncologist Discusses Concerns With Incoming CMS Payment Model

Allison Inserro
As CMS prepares to move forward with new models of value-based cancer care, a radiation oncologist, speaking at the Institute for Value-Based Medicine®, discussed her findings regarding whether accountable care models had an effect on cancer care spending.
Site Logo
December 18th 2019

Hope and Some Skepticism Whether Oncology Payment Models Will Work

Allison Inserro
Coverage from the Institute for Value-Based Medicine® session held in Nashville, Tennessee.
Risk of Heart Failure Greater in Patients With AML, ALL on Anthracyclines
December 18th 2019

Risk of Heart Failure Greater in Patients With AML, ALL on Anthracyclines

Maggie L. Shaw
In cases of acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL), there is a greater risk of symptomatic heart failure in the first year following initiation of anthracycline treatment.
Government-Insured Patients With Breast Cancer Face a Higher Risk of Death
December 17th 2019

Government-Insured Patients With Breast Cancer Face a Higher Risk of Death

Gianna Melillo
Patients with breast cancer who have government insurance face a higher risk of death, according to a retrospective study presented at the 2019 San Antonio Breast Cancer Symposium on December 13.
Site Logo
December 17th 2019

From the Editor-in-Chief: Lead, Follow, or Get Out of the Way

Joseph Alvarnas, MD
Dr Alvarnas is editor-in-chief of Evidence-Based Oncology.™ He is vice president of Government Affairs, senior medical director for Employer Strategy, and associate clinical professor, Hematology & Hematologic Cell Transplantation, City of Hope, Duarte, Califonia.
Site Logo
December 16th 2019

Provider Perspective: Stephen M. Schleicher, MD, MBA, Addresses Accountability Versus Control in Oncology Care First

Mary Caffrey
An article Schleicher co-wrote in JAMA Oncology, which appeared the day before the announcement of Oncology Care First, offered insights into the need for changes to the original OCM.
Site Logo
December 16th 2019

Provider Perspective: Kashyap Patel, MD, Sees Collaboration Going Into Oncology Care First

Mary Caffrey
Kashyap Patel, MD, the chief executive officer of Carolina Blood and Cancer Care Associates—a leading OCM practice—and associate editor of Evidence-Based Oncology™ (EBO), said he’s optimistic about Oncology Care First.
Site Logo
December 16th 2019

Can Cancer Care Lead the Way Toward a Value-Based Future?

Keely Macmillan, MPH
A senior vice president of Archway Health discusses challenges and opportunities of the proposed Oncology Care First model.
Anthracycline, Radiation Treatment for Childhood Cancer Shown to Increase Risk of Adult Breast Cancer
December 12th 2019

Anthracycline, Radiation Treatment for Childhood Cancer Shown to Increase Risk of Adult Breast Cancer

Maggie L. Shaw
There was a 37% increase in childhood cancer survival between 1975 and 2010. With more children receiving chemotherapy and radiation to treat their diseases, leading to more survivors, awareness has grown of the belated effects of those treatments once patients reach adulthood.
Site Logo
December 11th 2019

Outcome Measures for Oncology Alternative Payment Models: Practical Considerations and Recommendations

Jakub P. Hlávka, PhD Pei-Jung Lin, PhD Peter J. Neumann, ScD
This review presents a set of evidence-based outcome measures for oncology alternative payment models, drawing on evidence from existing and proposed quality measures.
Supplemental MRI of Very Dense Breast Tissue Finds Early Cancers, at Higher Risk of False Positives
December 11th 2019

Supplemental MRI of Very Dense Breast Tissue Finds Early Cancers, at Higher Risk of False Positives

Gianna Melillo
A recent study published in The New England Journal of Medicine says that women with dense breast tissue who undergo supplemental magnetic resonance imaging (MRI) tests have lower rates of interval cancers than those who receive only mammography tests, although they also had higher rates of false positive tests.
Jennifer Atkins Describes Blue Cross Blue Shield's Commitment to Innovations in Oncology
December 8th 2019

Jennifer Atkins Describes Blue Cross Blue Shield's Commitment to Innovations in Oncology

Blue Cross Blue Shield is dedicated to maintaining local relationships to ensure they can provide the best care continuum to patients, said Jennifer Atkins, MBA, vice president of Network Solutions at Blue Cross Blue Shield.
NHS Staffing Shortages Behind Delays in Cancer Diagnoses for Patients in UK
December 7th 2019

NHS Staffing Shortages Behind Delays in Cancer Diagnoses for Patients in UK

Gianna Melillo
Patients waited about 2 months longer than necessary for a cancer diagnosis in the United Kingdom, according to a study published this week.
Patients With Chemotherapy-Induced Cardiomyopathy Show Improvements in LVEF After Cardiac Resynchronization Therapy
December 4th 2019

Patients With Chemotherapy-Induced Cardiomyopathy Show Improvements in LVEF After Cardiac Resynchronization Therapy

Maggie L. Shaw
Heart issues in patients with cancer and survivors can present themselves months or years after treatment.
This Week in Managed Care: November 29, 2019
November 29th 2019

This Week in Managed Care: November 29, 2019

This week, the top managed care news included research that may hold the key to slowing progression of multiple sclerosis; Humana says it is saving billions of dollars through value-based care; the challenges of rural healthcare delivery.
Top 5 AJMC® Articles of November 2019
November 28th 2019

Top 5 AJMC® Articles of November 2019

Here are the top 5 articles for the month of November.
AJMC® Research Roundup: November 2019
November 27th 2019

AJMC® Research Roundup: November 2019

Here are 5 interesting findings from the November 2019 issue of AJMC®.
ASCO Updates Patient-Centered Oncology Payment Model
November 27th 2019

ASCO Updates Patient-Centered Oncology Payment Model

Maggie L. Shaw
After a request for additional input from oncologists, practice administrators, payer representatives, and experts in physician payment and business analysis, ASCO has issued updated guidance on PCOP. With CMS’ Oncology Care Model set to end in 2021, the current draft of ASCO’s Community-based Oncology Medical Home model would be an option to take its place.
Dr James Hamrick Offers Advice for Providers Looking to Implement Patient Engagement Programs
November 25th 2019

Dr James Hamrick Offers Advice for Providers Looking to Implement Patient Engagement Programs

The biggest advice I would give to practices and care teams trying to really engage patients more is be innovative, explained James Hamrick, MD, senior medical director at Flatiron Health.
Dr Joshua Ofman: Early Detection of Cancer Is Vital to the Progression of Oncology Care
November 22nd 2019

Dr Joshua Ofman: Early Detection of Cancer Is Vital to the Progression of Oncology Care

GRAIL has generated enormous innovations in oncology care over the past 2 decades and will continue this trend through exploring 1 of oncology’s biggest opportunities, early detection of cancer, said Joshua Ofman, MD, chief of Corporate Strategy and External Affairs at GRAIL Inc.
What We're Reading: Vaping Ban Bill; Anal Cancer Rates; Medical Bill Protections
November 20th 2019

What We're Reading: Vaping Ban Bill; Anal Cancer Rates; Medical Bill Protections

AJMC Staff
A House committee approves a bill to ban all flavored tobacco products; anal cancer rates are on the rise; the debate continues over competing healthcare measures.
Nina Chavez on Whether Biosimilars Will Offer Cost Savings in Oncology
November 16th 2019

Nina Chavez on Whether Biosimilars Will Offer Cost Savings in Oncology

Nina Chavez, MBA, FACMPE, chief operating officer, New Mexico Oncology Hematology Consultants, Ltd., discusses if she thinks biosimilars will play a role in lowering costs in coming years.
Dr James Hamrick on Challenges With Understanding, Acting on What Constitutes Value for Patients
November 13th 2019

Dr James Hamrick on Challenges With Understanding, Acting on What Constitutes Value for Patients

James Hamrick, MD, senior medical director at Flatiron Health, discusses some of the biggest challenges with trying to understand what constitutes value for patients and then turning that into actionable information.
Erich Mounce: Providing Relevant Data to Provider Practices Encourages Growth
November 12th 2019

Erich Mounce: Providing Relevant Data to Provider Practices Encourages Growth

Providing providers with relevant data on quality of care and profitability allows them to adjust their practices efficiently, said Erich Mounce, chief operating officer, OneOncology.
Site Logo
November 12th 2019

Multimodality Cancer Care and Implications for Episode-Based Payments in Cancer

Suhas Gondi, BA Alexi A. Wright, MD, MPH Mary Beth Landrum, PhD Jose Zubizarreta, PhD Michael E. Chernew, PhD Nancy L. Keating, MD, MPH
Most patients receiving multimodality cancer care receive care from different practices. Therefore, episode-based payments in oncology must hold multiple providers accountable for costs and quality.
<1
...
192021222324252627
...
184>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo